Abstract:PURPOSE: Currently, serum biomarkers that are sufficiently sensitive and specific for early detection and risk classification of gastric adenocarcinomas are not known. In this study, ten serum markers were assessed using the Luminex system and enzyme-linked immunosorbent assay for the diagnosis of gastric cancer and analysis of the relation between prognosis and metastases.PATIENTS AND METHODS: A training set consisting of 228 gastric adenocarcinoma and 190 control samples was examined. A Luminex multiplex panel with nine biomarkers, consisting of three proteins discovered through our previous studies and six proteins previously reported to be cancer-associated, was constructed. One additional biomarker was detected using a commercial kit containing EDTA. Logistic regression, random forest (RF), and support vector machine (SVM) were used to identify the panel of discriminatory biomarkers in the training set. After selecting five proteins as candidate biomarkers, multivariate classification analyses were used to identify algorithms for diagnostic biomarker combinations. These algorithms were independently validated using a set of 57 gastric adenocarcinoma and 48 control samples.RESULTS: Serum pepsinogen I, serum pepsinogen II, A Disintegrin And Metalloproteinase domain-containing protein 8 (ADAM8), vascular endothelial growth factor (VEGF), and serum IgG to Helicobacter pylori were selected as classifiers in the three algorithms. These algorithms differentiated between the majority of gastric adenocarcinoma and control serum samples in the training/test set with high accuracy (RF 79.0%, SVM 83.8%, logistic regression 76.2%). These algorithms also differentiated the samples in the validation set (accuracy: RF 82.5%, SVM 86.1%, logistic regression 78.7%).CONCLUSION: A panel of combinatorial biomarkers comprising VEGF, ADAM8, IgG to H. pylori, serum pepsinogen I, and pepsinogen II were developed. The use of biomarkers is a less invasive method for the diagnosis of gastric adenocarcinoma. They may supplement clinical gastroscopic evaluation of symptomatic gastric cancer patients and enhance the diagnostic accuracy.

Progress in the Serum Markers of Gastric Precancerous Lesions and Gastric Cancer

Advances in Clinical and Pathological Diagnosis of Chronic Gastritis

[Advances in Serum Biomarkers for Early Diagnosis of Gastric Cancer].

Application of serum gastric function markers and digestive tumor indices to the diagnosis of early gastric cancer and precancerous lesions

Serum tumor markers (carcinoembryonic antigen, carbohydrate antigen 19-9, carbohydrate antigen 72-4, carbohydrate antigen 24-2, ferritin) and gastric cancer prognosis correlation

Progress in the clinical research of gastric cancer

Evaluation of the value of combined detection of tumor markers CA724, carcinoembryonic antigen, CA242, and CA19-9 in gastric cancer

Serum biomarker panels for the diagnosis of gastric cancer

Review of recent efforts to discover biomarkers for early detection, monitoring, prognosis, and prediction of treatment responses of patients with gastric cancer

Novel biomarkers for early detection of gastric cancer

Serum biomarker panels for diagnosis of gastric cancer

Predicting Peritoneal Dissemination Of Gastric Cancer In The Era Of Precision Medicine: Molecular Characterization And Biomarkers

Non-Invasive Markers for the Detection of Gastric Precancerous Conditions

Serum proteomic profiling of precancerous gastric lesions and early gastric cancer reveals signatures associated with systemic inflammatory response and metaplastic differentiation

Molecular aspects in the diagnosis of gastric cancer

Advances in Research on Clinical Detection of Lymph Node Metastasis in Early Gastric Cancer

Temporal Changes in Serum Biomarkers and Risk for Progression of Gastric Precancerous Lesions: a Longitudinal Study.

Clinical significance of serum tumor marker for advanced gastric cancer with palliative chemotherapy: A retrospective study.

Global progress and future prospects of early gastric cancer screening

Preliminary study on proteomics of gastric carcinoma and its clinical significance.

Serum phospholipids are potential biomarkers for the early diagnosis of gastric cancer